The licensing racket.Meta is not a monopoly.KFF debate on drug pricing in the US. Use of AI by pharmaceutical manufacturers.FDA and agentic AI.
April 23, 2026
- How are payers and providers using AI? And why isn’t AI reducing administrative cost?
- How the DOJ Is Tackling Fraud in the ACA Marketplace
- FDA Nod for Merck HIV Drug Brings Competition to a Gilead Sciences Antiretroviral
- Legislative Efforts to Curb Prescription Drug Prices Gain Momentum Across the U.S.
Headlines
